Watanabe, Yoshifumi
Mizushima, Tsunekazu https://orcid.org/0000-0002-0825-6823
Okumura, Ryu
Fujino, Shiki
Ogino, Takayuki
Miyoshi, Norikatsu
Takahashi, Hidekazu
Uemura, Mamoru
Matsuda, Chu
Yamamoto, Hirofumi
Takeda, Kiyoshi
Doki, Yuichiro
Eguchi, Hidetoshi
Funding for this research was provided by:
Grants-in-Aid for Scientific Research 'KAKENHI' (19K18147)
Astellas Pharma Global Development (IDRS2017A000577)
Mitsubishi Tanabe Pharma Corporation (MTPS20180505001)
Article History
Received: 30 September 2020
Accepted: 11 May 2021
First Online: 26 May 2021
Declarations
:
: The authors declare no conflict of interest.
: Informed consent was obtained from all individual participants included in the study. All procedures involving human participants were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.